Annual income statement for Medikit Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 20,131 | 21,607 | 21,851 | 22,553 | 23,781 |
| Cost of Revenue | |||||
| Gross Profit | 8,181 | 8,319 | 8,753 | 8,668 | 9,008 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15,763 | 17,368 | 17,181 | 18,068 | 19,510 |
| Operating Profit | 4,368 | 4,239 | 4,670 | 4,485 | 4,271 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4,473 | 4,291 | 4,775 | 4,660 | 4,512 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,993 | 2,865 | 3,069 | 3,014 | 3,006 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,993 | 2,865 | 3,069 | 3,014 | 3,006 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,993 | 2,865 | 3,069 | 3,014 | 3,006 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 181 | 168 | 202 | 218 | 219 |
| Dividends per Share | |||||
| Special Dividends per Share |